Anthropic has filed registration documents with the SEC as it prepares for a Nasdaq IPO under the planned ticker ANT.

Offering status

The company has not disclosed the offering price or the placement size, and those details remain undetermined at this stage.

Financial results for H1 2026

In H1 2026, Anthropic reported revenue of $16.29 billion, versus $1.16 billion a year earlier, representing approximately a fourteenfold increase.

Net loss for the period totaled $80.75 billion, including $72.4 billion associated with the revaluation of financial instruments amid the company's valuation rise.

Anthropic stated that the $72.4 billion revaluation item does not represent direct operational expenses for the Claude product.

Accounting context

Valuation-driven revaluations of financial instruments are non-cash accounting entries that can arise when companies adjust mark-to-market positions or equity-linked instruments after funding rounds.

Such items can materially affect reported profit or loss while not reflecting the ongoing cash costs of product development or operations.

Key facts

• SEC filing: registration documents submitted ahead of Nasdaq listing.
• Ticker: ANT.
• H1 2026 revenue: $16.29 billion.
• H1 2025 revenue: $1.16 billion.
• Net loss: $80.75 billion, including $72.4 billion revaluation.

The SEC submission begins the formal registration process; further disclosures are expected as the company advances toward a potential listing on Nasdaq.